NOT-DA-21-032 NOSI: Administrative Supplements for Research on Fentanyl and Derivatives

Applications will be accepted anytime through March 31, 2022 by 5:00 PM local time of the applicant organization. 

Funder: NIH National Institute on Drug Abuse (NIDA)

NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on fentanyl and derivatives. NIDA is interested in supporting research to understand the public health impact, clinical characteristics, and treatment of fentanyl addiction and overdose and how they differ from liabilities associated with morphinan-opioids. NIDA is especially interested in research examining the risks and outcomes of fentanyl addiction and overdose.

Learn More Contact OSR to Apply

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Long-term Impact of Infection, Pneumonia, Co-Morbidities, Asthma, COPD, COVID-19, Substance Abuse